CYP2D6 HhaI genotype and the neuroleptic malignant syndrome.

doi:10.1159/000026557

Back to search

Article

CYP2D6 HhaI genotype and the neuroleptic malignant syndrome.

Neuropsychobiology - 1 Jan 1999

Iwahashi K, Yoshihara E, Nakamura K, Ameno K, Watanabe M, Tsuneoka Y, Ichikawa Y, Igarashi K

Abstract excerpt

To investigate the relationship between CYP2D6 genotypes (reported to be associated with the susceptibilities to Parkinson's disease and multisystem atrophy) and the possible susceptibility to neuroleptic malignant syndrome (NMS) and subacute myelo-optico-neuropathy (SMON), we analyzed the CYP2D6...

Topics

Adult
Cytochrome P-450 CYP2D6
Female
Genotype
Humans
Japan
Male
Middle Aged
Mutation
Myelitis
Neuroleptic Malignant Syndrome
Optic Neuritis
Polymorphism, Restriction Fragment Length
Schizophrenia

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.